Home / Education

A trusted knowledge hub

Science-backed, jargon-free resources on natural psychedelics and personal growth — translating complex research into practical understanding.

Flagship Book · Free

The Mushroom as a Chemical System

Our comprehensive, illustrated exploration of psilocybin mushrooms not as one molecule, but as a living chemical system. It travels from the ethnobotanical roots — teonanácatl, the Mazatec velada, María Sabina — through biosynthesis and the "entourage" of related compounds, dosing and variability, cultivation, the brain mechanism behind the experience, and the ethics of traditional knowledge.

Written in the Metanoia voice: rigorous enough for experts, clear enough for someone meeting the subject for the first time — with an illustration for every concept.

~49 pages 23 illustrations 12 tables 72 sources

Read the book   See what's inside

Opening chapters free to read now. Full edition releasing soon — written first in Hebrew, English edition in preparation.

What's Inside

Thirty parts, one living system

From the sacred mushroom of the Mazatec highlands to the labs racing toward approval in 2026 — the whole arc, each concept paired with its own illustration.

I

Roots & the sacred

Teonanácatl, the Mazatec velada, María Sabina and Wasson; three traditions — mushrooms, ayahuasca, iboga — and the mechanism that unites them: neuroplasticity and BDNF.

II

The chemistry

The 3.5 chemical families; tryptamines, beta-carbolines, terpenes; the PsiD/H/K/M biosynthesis pathway; and who actually crosses the blood-brain barrier.

III

The entourage effect

The four-tier evidence ladder for whether the whole mushroom differs from isolated psilocybin — the field's most consequential open question.

IV

Dose, freshness & variability

Dosing and the TPE model, onset and timing, fresh vs. dried, shelf life, water content — why two grams are never quite the same two grams.

V

Species & cultivation

Reframed around five species; growth stages and substrates species-by-species; and heterologous production in yeast, E. coli, and tobacco.

VI

The brain mechanism

REBUS, the CSTC loop, and intracellular neuroplasticity (Vargas/Olson); plus a dedicated look at hallucinations and Klüver's form constants.

VII

Tolerance, comparison, safety

Tolerance kinetics, how it compares across psychedelics, and a global map of regulation and safety — including the 2026 approval race.

VIII

Frontiers

Psychedelics and human development; why traditional psychedelic cultures are fading; and the shift the whole book points toward — from healing to thriving.

+

Open questions & heterodox views

Throughout: the honest edges — "illusion or hidden reality?", information in fungal networks, correlation vs. causation — marked by reliability, never dismissed.

Metanoia Press · The Library

One book out. A shelf on the way.

Each classic psychedelic deserves the same treatment we gave the mushroom — the whole story, told clearly and honestly. This is the plan for the library, one title at a time.

Available now

The Mushroom as a Chemical System

Psilocybin mushrooms, read as a living whole. Free to read.

Read it →

In preparation · Natural

DMT

The visionary molecule — chemistry, mind, and tradition.

Preview →

In preparation · Natural

Ayahuasca

Two plants, one brew, and the pharmacology that makes it work.

Preview →

In preparation · Natural

Mescaline

Peyote, San Pedro, and one of the oldest sacred medicines.

Preview →

In preparation · Natural

5-MeO-DMT

The "God molecule" — from toad and plant to the clinic.

Preview →

In preparation · Natural

Iboga

The Bwiti root, ibogaine, and a very different kind of journey.

Preview →

In preparation · Synthetic

LSD

The molecule that started the modern story — told in full.

Preview →

In preparation · Synthetic

MDMA

The empathogen — its chemistry, its promise, and its limits.

Preview →

…and every other natural psychedelic, in time. Get notified as each is released →

Learn Center

Start here

Foundations

Psychedelics 101

What natural psychedelics are — psilocybin mushrooms, mescaline cacti, and more — how they work in the brain, and their history.

Read more

Psychedelics 101

The classic psychedelics are a small family. Most are naturalpsilocybin mushrooms, mescaline (peyote and San Pedro cacti), DMT and the ayahuasca brew, 5-MeO-DMT from certain plants and the Sonoran toad, and iboga from Central Africa. Only two are true synthetics: LSD and MDMA.

Nearly all of them work through one doorway — the brain's 5-HT2A serotonin receptor — and share a deeper thread: neuroplasticity, the brain's capacity to rewire itself, which shows up across mushrooms, ayahuasca, and iboga alike.

Their history is far older than the science: Indigenous peoples used them ceremonially for millennia before Western chemistry gave them names in the 1950s. Our full guide walks through each one — how it works, where it comes from, and where the 2026 science stands.

Read the full guide →

Growth

Science of Personal Growth

How psychedelics may enhance creativity, emotional well-being, mindfulness, problem-solving, perception, and empathy.

Read more

The Science of Personal Growth

Almost all psychedelic research asks: can it treat illness? Metanoia asks a different question — what about the healthy person who simply wants to thrive? The shift is from returning to zero to reaching above it: creativity, emotional depth, openness, meaning, connection.

The honest state of the evidence is "promising, and unproven," and we hold both words together. There are real threads — a durable rise in the trait of openness after even single sessions in healthy volunteers, and a plasticity window that seems tailor-made for deliberate growth. There are also claims running far ahead of the data, which we flag as such.

Growth is harder to measure than the lifting of a symptom — which makes it both a richer goal and an easier one to oversell. We map it without flattering it.

Read the full page →

Safety

Safe Use & Integration

Why set and setting matter, the role of a sitter, and integration practices after the experience.

Read more

Safe Use & Integration

The physiological risk of psilocybin itself is low, but that is not the same as harmless. The real hazards are psychological and contextual — and they are manageable when respected.

  • Set and setting — your state of mind and your surroundings are the primary determinant of whether an experience heals or harms.
  • Contraindications — those with a personal or family history of psychosis or bipolar disorder should not use psychedelics; combinations with certain antidepressants and especially MAO-inhibitors can be dangerous.
  • Dose honesty — a gram is a weak predictor of strength; natural potency varies severalfold.
  • Integration — the reflective work afterward is where insight becomes lasting change.

This is education and harm reduction, not medical advice or a supply service.

Read the full page →

Ethics

Ethics & Legality

The legal status of these substances, sustainable sourcing, and why Metanoia focuses on natural ones.

Read more

Ethics & Legality

The legal map is being redrawn fast and differs everywhere. In much of the world psilocybin remains prohibited; a growing number of places are decriminalizing it or opening supervised access, and the first formal therapeutic approvals are likely within a few years.

Beyond the law sits a deeper debt. These mushrooms reached the modern world through Indigenous knowledge — Mazatec, Zapotec, and others — that was taken freely and repaid poorly. We hold that ethical debt at the center: reciprocity and credit rather than appropriation, and sustainable, cultivated sourcing rather than the stripping of wild populations.

It is one reason we focus on natural sources studied as whole systems — and always within the law, as research and education.

Read the full page →

Answers

FAQ

Are psychedelics legal? Does Metanoia provide drugs? How can I get involved in research? Straight answers.

Read more

Frequently Asked Questions

Does Metanoia provide psychedelics?

No. Metanoia conducts and shares research and public education. We do not supply, sell, or source any controlled substance.

Are psychedelics legal?

It depends entirely on where you are. In most places psilocybin remains a controlled substance. Some U.S. states and other jurisdictions have decriminalized it or created supervised-use programs. Always know your local law.

Is this medical advice?

No. Our content is educational. It is not a substitute for a doctor or a licensed therapist.

How can I get involved?

You can volunteer your skills, support the work, or join our list for updates.

See all questions →

Media

Articles & Videos

Research explained in plain language, talks, and visual explainers — added over time.

Read more

Articles & Videos

We translate complex, fragmented research into things people can actually understand: plain-language explainers, illustrated summaries, talks, and short videos. The goal is rigor without jargon — accurate enough for a specialist, clear enough for someone meeting the subject for the first time.

Our first major piece of published education is the free book The Mushroom as a Chemical System. More articles and visual explainers are being added over time, drawn from the same verified research base — and our News page keeps a running, source-checked digest of what's moving in the science.

Read the book →   See the latest →

What the science is telling us

A growing body of research suggests that, used carefully, natural psychedelics can support openness, introspection, and emotional well-being in healthy people — with neuroplasticity (the brain's ability to reorganize and form new connections) emerging as a shared thread across substances and traditions. Recent work also points to something important for our mission: for growth in healthy individuals, the subjective experience may not be a side effect to engineer away — it may be the point.

Metanoia's role is to gather and present the full picture — the consensus, the debates, and the open questions — clearly and honestly, so you can understand it for yourself.

See our research agenda →